scPharmaceuticals Inc. (SCPH)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.29
0.06 (1.86%)
At close: Jan 28, 2025, 3:36 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -54.81M | -36.84M | -28.03M | -32.21M | -33.00M | -29.44M | -23.82M | -24.38M | -10.52M |
Depreciation & Amortization | 626.00K | 468.00K | 438.00K | 399.00K | 364.00K | 332.00K | 167.00K | 5.00K | 4.00K |
Stock-Based Compensation | 4.86M | 2.84M | 2.37M | 2.00M | 1.45M | 2.13M | 947.00K | 876.00K | 379.00K |
Other Working Capital | 221.00K | -887.00K | -234.00K | 236.00K | -611.00K | -833.00K | -1.13M | -214.00K | -85.00K |
Other Non-Cash Items | -3.60M | -695.00K | 678.00K | 639.00K | 385.00K | 374.00K | 198.00K | 6.51M | -394.00K |
Deferred Income Tax | n/a | n/a | n/a | 30.00K | 2.00K | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.32M | -350.00K | -2.60M | 1.45M | 354.00K | -2.21M | -177.00K | 1.53M | 889.00K |
Operating Cash Flow | -59.24M | -34.58M | -27.15M | -27.69M | -30.44M | -28.81M | -22.68M | -15.46M | -9.64M |
Capital Expenditures | -40.00K | -21.00K | -9.00K | n/a | n/a | n/a | -194.00K | -9.00K | -17.00K |
Acquisitions | n/a | 45.84M | -32.14M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -50.59M | -67.54M | -9.01M | -72.16M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 70.60M | 21.70M | 41.15M | 38.70M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -45.84M | 32.14M | -33.46M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 19.96M | -45.86M | 32.13M | -33.46M | n/a | n/a | -194.00K | -9.00K | -17.00K |
Debt Repayment | n/a | 29.80M | -2.50M | n/a | 9.55M | -62.00K | 9.27M | 12.60M | n/a |
Common Stock Repurchased | n/a | n/a | -81.00K | -164.00K | n/a | -4.00K | -3.00K | n/a | -9.00K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 812.00K | -337.00K | -81.00K | -228.00K | 60.00K | 58.00K | 94.00K | 40.57M | 8.03M |
Financial Cash Flow | 14.85M | 77.23M | -2.53M | 60.35M | 13.59M | -8.00K | 102.07M | 53.17M | 8.02M |
Net Cash Flow | -24.43M | -3.21M | 2.45M | -805.00K | -16.85M | -28.82M | 79.20M | 37.71M | -1.64M |
Free Cash Flow | -59.28M | -34.60M | -27.16M | -27.69M | -30.44M | -28.81M | -22.88M | -15.46M | -9.66M |